Comparison of treatment effect sizes from pivotal and postapproval trials of novel therapeutics approved by the FDA based on surrogate markers of disease: a meta-epidemiological study

Evaluating the evidence used by the US Food and Drug Administration during the drug approval process

On Medicine, 18 May 2018

FDA’s approval process: Pivotal trials, patient-relevant endpoints, and surrogate markers In the US, the FDA is responsible…